Home » Thought Leadership » Page 5

Thought Leadership

Read our insights and commentary about industry news and innovation globally. Subscribe to our monthly newsletter to keep up to date with our thought leadership, news, and updates.

Showing 5 of 30 posts
May 29, 2019 | Blog

Central Nervous System (CNS) Drug Development Strategy: What is the Role of External Investment in this High-Risk Disease Space?

PART I of CBPartners' CNS series: the concept of external investment may represent a positive trend in the neuroscience space where different size firms are focused on their comparative strengths.

May 28, 2019 | Videos

Which disease states are on US payers’ radar?

US Market Access Trends: CBPartners' Andrew Gould asks a panel of US payers which disease states are currently on their radar.

May 20, 2019 | Videos

Will innovative contracts gain momentum in the future?

US Market Access Trends: CBPartners' Andrew Gould asks a panel of US payers whether they think that innovative contracts will gain momentum in the future.

May 12, 2019 | Research posters

ISPOR International 2019: The Importance of Overall Survival as a Clinical Endpoint in FDA vs. EMA Regulatory Approval

ISPOR International 2019: CBPartners presented a poster about the importance of overall survival (OS) data as a clinical endpoint in FDA vs. EMA regulatory approval.

May 9, 2019 | Videos

What is the role of ICER today and in the future?

US Market Access Trends: CBPartners' Andrew Gould asks a panel of US payers what they see the role of ICER being today, and becoming in the future.